Protocol for Suspicious Lesions

All patients at an increased risk should receive a ViziLite Plus exam annually following a conventional soft tissue examination.  Highest risk patients, particularly patients with a history of oral cancer, may benefit from a ViziLite Plus exam on a more frequent basis as determined by a clinician's judgment.

For lesions identified during the ViziLite examination:

• Document the clinical appearance and location of the lesion on the ViziLite Plus mouth map. If possible, photograph the lesion.
• If trauma or inflammation cannot be ruled out, have the patient return for re-evaluation in 7-14 days. At re-evaluation if the lesion persists, document it noting any deviations.
• If the lesion is considered suspicious, especially if it is detected in a high risk site for oral caner, apply the TBlue ⁶³⁰ oral lesion marking system. Document the results on the mouth map. If possible, photograph the lesion.
• If not 100% certain the lesion is benign, regardless of the TBlue⁶³⁰ retention, biopsy the lesion or refer the patient to a specialist for further assessment.

The ViziLite Plus exam map is central to this process and serves as the basis for all documentation. It allows you to 1) document the initial clinical appearance of abnormalities; 2) track progress by keeping a record of notes; 3) provide the central document for any billing requirements; and 4) For referral to specialist, along with an intraoral photograph if possible.

Download the Patient Waiver/Consent Form with Mouth Map